NCT00553488 - Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating | Biotech Hunter

Enrollment

30

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Regular insulin (Humulin)

Insulin will be given either subcutaneously or intra-dermally, and at two different times prior to the liquid meal (T zero). At -17 mins, regular insulin will be given either SC or ID. At -2 mins, regular insulin will be given ID; also insulin lispro will be given either SC or ID. Each patient will receive 1 injection on 5 different study days.

DRUG

Insulin lispro (Humalog)

Insulin will be given either subcutaneously or intra-dermally, and at two different times prior to the liquid meal (T zero). At -17 mins, regular insulin will be given either SC or ID. At -2 mins, regular insulin will be given ID; also insulin lispro will be given either SC or ID. Each patient will receive 1 injection on 5 different study days.

Trial Locations (1)

D-41460

Profil Institut fur Stoffwechselforschung GmbH, Neuss